Very few cases of patients with myasthenia gravis (MG) who later developed amyotrophic lateral sclerosis (ALS) have been described, although some studies showed that significantly more cases than expected have ALS associated with a prior diagnosis of autoimmune diseases. Our aim was to investigate whether the association of ALS and MG was higher than expected in a population-based study and to describe the clinical features characterizing these patients. In Emilia Romagna Region of Italy, a prospective registry has been collecting all incident ALS cases since 1.1.2009. For each patient, detailed clinical information is collected by caring physicians, including comorbidities. From 1.1.2009 to 31.12.2014, 671 patients were diagnosed with ALS; five patients (0.75%) were also affected by MG. Considering Western Countries incidence rates the occurrence of both the diseases should be a really exceptional event (7.5/10(9)), compared to our findings (1.87/10(7)) (p < 0.01). Patients with ALS and MG had more frequently a bulbar onset and a fast progressive course. These cases of ALS after MG raise the possibility of potential shared immunological dysfunctions, which may be expression of common pathogenic mechanisms, as well as of shared disease-course modulating events.

Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? / de Pasqua, Silvia; Cavallieri, Francesco; D'Angelo, Roberto; Salvi, Fabrizio; Fini, Nicola; D'Alessandro, Roberto; Rinaldi, Rita; Fasano, Antonio; Mandrioli, Jessica. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 38:3(2017), pp. 441-444. [10.1007/s10072-016-2787-3]

Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?

Cavallieri, Francesco;Fasano, Antonio;Mandrioli, Jessica
2017

Abstract

Very few cases of patients with myasthenia gravis (MG) who later developed amyotrophic lateral sclerosis (ALS) have been described, although some studies showed that significantly more cases than expected have ALS associated with a prior diagnosis of autoimmune diseases. Our aim was to investigate whether the association of ALS and MG was higher than expected in a population-based study and to describe the clinical features characterizing these patients. In Emilia Romagna Region of Italy, a prospective registry has been collecting all incident ALS cases since 1.1.2009. For each patient, detailed clinical information is collected by caring physicians, including comorbidities. From 1.1.2009 to 31.12.2014, 671 patients were diagnosed with ALS; five patients (0.75%) were also affected by MG. Considering Western Countries incidence rates the occurrence of both the diseases should be a really exceptional event (7.5/10(9)), compared to our findings (1.87/10(7)) (p < 0.01). Patients with ALS and MG had more frequently a bulbar onset and a fast progressive course. These cases of ALS after MG raise the possibility of potential shared immunological dysfunctions, which may be expression of common pathogenic mechanisms, as well as of shared disease-course modulating events.
38
3
441
444
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? / de Pasqua, Silvia; Cavallieri, Francesco; D'Angelo, Roberto; Salvi, Fabrizio; Fini, Nicola; D'Alessandro, Roberto; Rinaldi, Rita; Fasano, Antonio; Mandrioli, Jessica. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 38:3(2017), pp. 441-444. [10.1007/s10072-016-2787-3]
de Pasqua, Silvia; Cavallieri, Francesco; D'Angelo, Roberto; Salvi, Fabrizio; Fini, Nicola; D'Alessandro, Roberto; Rinaldi, Rita; Fasano, Antonio; Mandrioli, Jessica
File in questo prodotto:
File Dimensione Formato  
depasqua2016.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 340.29 kB
Formato Adobe PDF
340.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1177828
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact